Downregulated proteins in TAU Pro-Ile. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Fuzzy c-mean clustering. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Cluster 7—Gene Ontology. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Cluster 4—Gene Ontology. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Cluster 2—Gene Ontology. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Venn diagram—Down-regulated proteins. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Venn diagram—Up-regulated proteins. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Cluster 3—Gene Ontology. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Cluster 5—Gene Ontology. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Protein Groups Matrix. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Upregulated proteins in TAU Pro-Ile. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Cluster 1—Gene Ontology. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Cluster 6—Gene Ontology. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

Downregulated proteins in TAU Pro-Val. by Janaina de Freitas Nascimento (3849415)

“…<div><p><i>Trypanosoma cruzi</i>, the causative agent of Chagas disease, has a complex life cycle that involves triatomine insects as vectors and mammals as hosts. …”

DataSheet2_Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis.docx by Jung Hoon Cha (19723588)

“…Additionally, OATD-01-treated mice had lower CHIT1, F4/80, and α-smooth muscle actin positivity, as well as significantly lower levels of inflammatory markers, pro-fibrotic genes, and matrix remodeling-related mRNAs than vehicle-treated mice. …”

DataSheet1_Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis.zip by Jung Hoon Cha (19723588)

“…Additionally, OATD-01-treated mice had lower CHIT1, F4/80, and α-smooth muscle actin positivity, as well as significantly lower levels of inflammatory markers, pro-fibrotic genes, and matrix remodeling-related mRNAs than vehicle-treated mice. …”

Table 4_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx by Junzhe Chen (5729912)

“…Combined approaches achieved slightly lower reductions (87.31%), but significantly decreased compression dependence, improved lymphatic function, and enhanced QOL. …”

Table 3_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx by Junzhe Chen (5729912)

“…Combined approaches achieved slightly lower reductions (87.31%), but significantly decreased compression dependence, improved lymphatic function, and enhanced QOL. …”

Table 1_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.pdf by Junzhe Chen (5729912)

“…Combined approaches achieved slightly lower reductions (87.31%), but significantly decreased compression dependence, improved lymphatic function, and enhanced QOL. …”

Table 2_Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis.docx by Junzhe Chen (5729912)

“…Combined approaches achieved slightly lower reductions (87.31%), but significantly decreased compression dependence, improved lymphatic function, and enhanced QOL. …”